Dr Bradlee Heckmann and his team at the USF Health Neuroscience Institute in the US aim to develop new therapeutic avenues for treating neuroinflammatory and neurodegenerative diseases, including Alzheimer’s. Read their original article here: <a href='http://doi.org/10.4103/1673-5374.317958'>http://doi.org/10.4103/1673-5374.317958</a> Read more about their work in <a href='http://doi.org/10.4103/1673-5374.317958'>Research Features</a>

Dr Bradlee Heckmann and his team at the USF Health Neuroscience Institute in the US aim to develop new therapeutic avenues for treating neuroinflammatory and neurodegenerative diseases, including Alzheimer’s. Read their original article here: http://doi.org/10.4103/1673-5374.317958 Read more about their work in Research Features

Dr Bradlee Heckmann and his team at the USF Health Neuroscience Institute in the US aim to develop new therapeutic avenues for treating neuroinflammatory and neurodegenerative diseases, including Alzheimer’s. Read their original article here: <a href="http://doi.org/10.4103/1673-5374.317958" rel="noopener noreferrer">http://doi.org/10.4103/1673-5374.317958</a> Read more about their work in <a href="http://doi.org/10.4103/1673-5374.317958" rel="noopener noreferrer">Research Features</a>

New therapeutic avenues for treating Alzheimer’s disease

ResearchPod science podcasts connect the research community to a global audience of peers and the public, raising visibility and impact. www.researchpod.org. All content is shared under the Creative Commons CCBY-NC-ND 4.0 licence. For further information, email contact@researchpod.org

Share New therapeutic avenues for treating Alzheimer’s disease

Sign up to save your podcasts

New therapeutic avenues for treating Alzheimer’s disease

New therapeutic avenues for treating Alzheimer’s disease

More shows like ResearchPod

Global News Podcast